reports
Globus Medical Schedules First Quarter Earnings Release and Conference...
Globus Medical Schedules First Quarter Earnings Release and Conference Call AUDUBON, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, May 7, 2024. A copy of the release will be available on the Globus Medical website at . Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call live...
Stryker to announce financial results for its first quarter of fiscal ...
Stryker to announce financial results for its first quarter of fiscal year 2024 Portage, Michigan, April 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, April 30, 2024. A press release will be issued at approximately 4:05pm ET and available at that day. The press release will include summary financial information for the company’s first quarter of fiscal year 2024, that ended March 31, 2024. Stryker will host a webcast at 4:30pm ET on Tuesday, April 30, to discuss results for its first quar...
Stryker announces Annual Meeting of Shareholders
Stryker announces Annual Meeting of Shareholders Portage, Michigan, March 26, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2024 Annual Meeting of Shareholders is scheduled as follows: Thursday, May 9, 2024 – 9:30 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at To listen to the meeting as a guest dial (877) 328-2502 (U.S.) or (412) 317-5419 (International) and request the "Stryker...
Globus Medical Inc: 1 director
A director at Globus Medical Inc sold 10,590 shares at 51.990USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Alphatec Holdings Inc: 2 directors
Two Directors at Alphatec Holdings Inc sold after exercising options/bought 29,225 shares at between 12.830USD and 13.160USD. The significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by...
Moody's affirms Stryker Corporation's Baa1 senior unsecured rating, re...
Moody's Ratings (Moody's) affirmed Stryker Corporation's ("Stryker") Baa1 senior unsecured ratings, Baa1 long term issuer rating, and the company's Prime-2 commercial paper rating. At the same time, Moody's revised the outlook to positive from stable. The affirmation of Stryker's ratings reflects ...
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
Globus Medical Reports Fourth Quarter and Full Year 2023 Results AUDUBON, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2023. Fourth Quarter 2023: Worldwide net sales were $616.5 million, an increase of 124.6%, or 123.8% on a constant currency basisGAAP net income for the quarter was $15.0 millionGAAP diluted earnings per share (“EPS”) was $0.11 and non-GAAP diluted EPS was $0.60Non-GAAP adjusted EBITDA was $17...
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Re...
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call AUDUBON, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Tuesday, February 20, 2024. A copy of the release will be available on the Globus Medical website at . Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Parti...
Stryker Corp: 1 director
A director at Stryker Corp sold 9,600 shares at 342.808USD and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Stryker declares a $0.80 per share quarterly dividend
Stryker declares a $0.80 per share quarterly dividend Portage, Michigan, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable April 30, 2024 to shareholders of record at the close of business on March 29, 2024, representing an increase of 6.7% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and servic...
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chi...
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer Pfeil takes on expanded responsibilities while Globus fuels its next phase of growth AUDUBON, Pa., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the promotion of Keith Pfeil as chief operating officer (COO) and chief financial officer (CFO). Having served as the Company’s CFO since August 2019, in this expanded role, Pfeil will help further drive the Company's strategic roadmap through business and operational pla...
Stryker to participate in Citi’s 2024 Unplugged Medtech and Life Scien...
Stryker to participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day Portage, Michigan, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day on Thursday, February 29, 2024 at Citigroup Headquarters, New York, New York. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor Relations will represent the Company in a presentation scheduled for 1:45 p.m. Eastern Time. A simultaneous webcast and replay of the Company’s presentation will be available on St...
Stryker reports 2023 operating results and 2024 outlook
Stryker reports 2023 operating results and 2024 outlook Portage, Michigan, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2023: Fourth Quarter Results Reported net sales increased 11.8% to $5.8 billionOrganic net sales increased 11.4%Reported operating income margin of 21.6%Adjusted operating income margin(1) increased 60 bps to 27.2%Reported EPS increased 102.7% to $2.98Adjusted EPS(1) increased 15.3% to $3.46 Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant...
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year...
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results AUDUBON, Pa., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2023. The company anticipates fourth quarter 2023 sales of approximately $615.5 million, an increase of 124.2 percent over the fourth quarter 2022 on an as-reported basis. Full year 2023 sales are expected to be approximately $1.567 billion, an increase of 53.2 percent ove...
Stryker announces 2023 sales surpassed $20 billion
Stryker announces 2023 sales surpassed $20 billion Portage, Michigan, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that it surpassed $20 billion in annual sales for the first time in its history during the month of December, 2023. “We are excited to surpass this major milestone and to share with our employees as we have our kick-off meetings for 2024,” said Kevin Lobo, Chair and Chief Executive Officer. “This means that we are positively impacting more customers and patients than ever.” Stryker will disclose additional information regarding its 2023 financi...
Stryker to announce financial results for its fourth quarter and full ...
Stryker to announce financial results for its fourth quarter and full year 2023 Portage, Michigan, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for fourth quarter and full year 2023 on Tuesday, January 30, 2024. A press release will be issued at approximately 4:05pm ET and available at that day. The press release will include summary financial information for the company’s fourth quarter and full year 2023, that ended December 31, 2023. Stryker will host a webcast at 4:30pm ET on Tuesday, January 30, 2024, to discuss results for ...
Medtronic Plc: 1 director
A director at Medtronic Plc sold 4,997 shares at 82.170USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.